Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study Multicentric Phamacological no Profit for the Treatment of Patients With Hemoglobinopathies and Rare Inherited Anemia Affected by Covid 19

NCT04746066 is registered in ClinicalTrials.gov with Società Italiana Talassemie ed Emoglobinopatie as lead sponsor.

NCT NCT04746066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04746066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study Multicentric Phamacological no Profit for the Treatment of Patients With Hemoglobinopathies and Rare Inherited Anemia Affected by Covid 19
Lead sponsor
Società Italiana Talassemie ed Emoglobinopatie
Phase
Observational
Overall status
Recruiting
Start date
March 31, 2020
Completion date
December 31, 2030
Enrollment
10,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

haemoglobinopathies